← ANALYSTS · TIPRANKS
Jonathan Wolleben · Citizens JMP
Hits
53%
267 of 500 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating
+23.6%
Over a year after the rating, TipRanks’ measure
Our companies rated now
18
Buy / hold / sell: 16 / 1 / 1
Upside of the analyst’s targets
+239.5%
Average over 16 current targets, to the last price
The market’s answer to the ratings
+3.8%
Day-0 move against SPY in the rating’s direction, average over 14 upgrades, downgrades and target changes
| Date · added, NY | Stock | Action | Rating | Price target | Upside | Move vs SPY | |
|---|---|---|---|---|---|---|---|
| Oct 1on TipRanks 05:50 | SGMTIWMSagimet Biosciences, Inc. Class A · $575M | Reiterated | Buy | $29.00 → $27.00−6.9% | +236.7% | −5.3%next day −3.2% · 5 days −6.1% | ↗ |
| Sep 9on TipRanks 06:00 | PHVSPharvaris · $2.1B | Reiterated | Buy | $75.00 → $79.00+5.3% | +184.8% | +0.2%next day 0.0% · 5 days +0.6% | ↗ |
| Aug 31on TipRanks 14:20 | PTGXIWMProtagonist Therapeutics · $8.8B | Reiterated | Buy | $165 → $170+3.0% | +32.0% | +2.7%next day −0.2% · 5 days −1.1% | ↗ |
| Aug 10on TipRanks 12:00 | SIONIWMSionna Therapeutics, Inc. · $184M | Downgrade | Hold | — | — | −91.2%next day +13.7% · 5 days +31.4% | ↗ |
| Aug 6on TipRanks 05:55 | MIRMIWMMirum Pharmaceuticals · $5.3B | Reiterated | Buy | $146 → $137−6.2% | +71.0% | −10.9%next day +6.3% · 5 days +3.7% | ↗ |
| Aug 5on TipRanks 05:55 | RYTMIWMRhythm Pharmaceuticals · $6.0B | Reiterated | Buy | $155 → $160+3.2% | +85.7% | +4.9%next day +1.4% · 5 days +5.9% | ↗ |
| Jul 21on TipRanks Jul 24 05:09 | ANNXIWMAnnexon Biosciences · $682M | Initiated | Sell | $3.00 | −12.0% | −4.1%next day −2.9% · 5 days −6.8% | ↗ |
| Jul 17on TipRanks 05:25 | MDGLMadrigal Pharmaceuticals · $10.4B | Reiterated | Buy | $737 → $739+0.3% | +64.3% | +2.4%next day −3.1% · 5 days −1.0% | ↗ |
| Jun 30on TipRanks 06:08 | DBVTDBV Technologies SA - American · $719M | Reiterated | Buy | $55.00 | +507.7% | +1.7%next day −3.9% · 5 days +2.3% | ↗ |
| May 19on TipRanks 05:45 | SGMTIWMSagimet Biosciences, Inc. Class A · $575M | Reiterated | Buy | $35.00 → $12.00−65.7% | +49.6% | −1.1%next day +0.7% · 5 days +8.1% | ↗ |
| May 14on TipRanks 06:00 | SPRBIWMSpruce Biosciences · $119M | Reiterated | Buy | $170 → $150−11.8% | +278.3% | +1.7%next day −7.6% · 5 days −9.9% | ↗ |
| May 14on TipRanks 05:50 | ALTIWMAltimmune · $459M | Reiterated | Buy | $14.00 → $11.00−21.4% | +400.0% | −4.1%next day −1.2% · 5 days +1.1% | ↗ |
| May 13on TipRanks 06:00 | IRDIWMOpus Genetics · $337M | Reiterated | Buy | $12.00 → $11.00−8.3% | +186.5% | −3.5%next day −2.0% · 5 days −11.6% | ↗ |
| May 12on TipRanks 05:50 | MBXIWMMBX Biosciences, Inc. · $2.4B | Reiterated | Buy | $76.00 → $86.00+13.2% | +73.4% | −7.6%next day +0.8% · 5 days −17.2% | ↗ |
| May 7on TipRanks 05:55 | BCRXIWMBioCryst · $2.0B | Reiterated | Buy | $25.00 → $28.00+12.0% | +259.4% | +1.1%next day −4.0% · 5 days +5.3% | ↗ |
| Mar 12on TipRanks Mar 27 18:00 | PRQRProQR · $228M | Reiterated | Buy | $8.00 | +510.7% | −3.5%next day +6.4% · 5 days −6.6% | |
| Feb 17on TipRanks 14:20 | OCULIWMOcular Therapeutix · $1.6B | Reiterated | Buy | — | — | −21.4%next day −2.1% · 5 days +27.5% | ↗ |
| Oct 23on TipRanks 04:55 | SVRAIWMSavara · $974M | Reiterated | Buy | $8.00 → $11.00+37.5% | +147.2% | −0.4%next day +5.0% · 5 days +3.2% | ↗ |
| Oct 6on TipRanks 08:55 | LRMRIWMLarimar Therapeutics · $207M | Reiterated | Buy | $18.00 | +806.8% | −1.6%next day −1.5% · 5 days −10.4% | ↗ |
| No ratings for this filter. | |||||||
Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗